Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26686043

Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Haematol
Publication date
2015 Oct
First author
Platzbecker U

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Haematol. 2015 Oct;2(10):e396-7. doi: 10.1016/S2352-3026(15)00200-8.
    note
    Source null
    related pmid
    26686035
    relationship
    Comment in

Authors and identifiers

  1. name
    Platzbecker U
    type
    Author
  2. name
    Wong RS
    type
    Author
  3. name
    Verma A
    type
    Author
  4. name
    Abboud C
    type
    Author
  5. name
    Araujo S
    type
    Author
  6. name
    Chiou TJ
    type
    Author
  7. name
    Feigert J
    type
    Author
  8. name
    Yeh SP
    type
    Author
  9. name
    Götze K
    type
    Author
  10. name
    Gorin NC
    type
    Author
  11. name
    Greenberg P
    type
    Author
  12. name
    Kambhampati S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Platzbecker U
    type
    Author
  2. name
    Wong RS
    type
    Author
  3. name
    Verma A
    type
    Author
  4. name
    Abboud C
    type
    Author
  5. name
    Araujo S
    type
    Author
  6. name
    Chiou TJ
    type
    Author
  7. name
    Feigert J
    type
    Author
  8. name
    Yeh SP
    type
    Author
  9. name
    Götze K
    type
    Author
  10. name
    Gorin NC
    type
    Author
  11. name
    Greenberg P
    type
    Author
  12. name
    Kambhampati S
    type
    Author
bibliography ids
  1. nci-bib-6dfbfc1c69b3d6922b2a36a1
book metadata
content sha256
5be76289a58de8d7667157088f3aabfd3322d5c80ba58701ea1acb94ac3a144a
document type
citation
dois
  1. 10.1016/S2352-3026(15)00149-0
electronic publication date
display
2015 Oct 1
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26686043
immutable id
pubmed:26686043@5be76289a58de8d7667157088f3aabfd3322d5c80ba58701ea1acb94ac3a144a
journal
abbreviation
Lancet Haematol
issn electronic
2352-3026
issn print
Source null
issue
10
name
The Lancet. Haematology
nlm unique id
101643584
pages
e417-26
volume
2
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Haematol. 2015 Oct;2(10):e396-7. doi: 10.1016/S2352-3026(15)00200-8.
    note
    Source null
    related pmid
    26686035
    relationship
    Comment in
outcomes validated
false
pmid
26686043
provenance
batch id
948d34b0dea86780a31d
provider
NCBI PubMed ESummary
record sha256
0117d0bcc71b23bf56421e79a2c80531a30a10a88c360d856a38c97db838b8db
response sha256
11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
retrieved at
2026-09-09T23:47:15.495091+00:00
publication date
display
2015 Oct
precision
month
year
2015
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26686043/
title
Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial.

Preserved source evidence · Not medical advice